Clinical phase III study on TAP-144-SR, an LH-RH agonist depot formulation, in patients with prostatic cancer

A randomized controlled phase III clinical trial comparing TAP-144-SR (TAP) and diethylstilbestrol diphosphate was conducted for patients with prostatic cancer. Patients with Stage B, C, or D disease, who were previously untreated, were enrolled. TAP-144-SR 3.75 mg was administered subcutaneously at...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hinyokika kiyo. Acta urologica Japonica. - 1962. - 37(1991), 3 vom: 15. März, Seite 305-20
1. Verfasser:	Aso, Y (VerfasserIn)
Weitere Verfasser:	Kameyama, S, Niijima, T, Ohmori, H, Ohashi, T, Murahashi, I, Akimoto, M, Koiso, K, Akaza, H, Hosaka, M
Format:	Aufsatz
Sprache:	Japanese
Veröffentlicht:	1991
Zugriff auf das übergeordnete Werk:	Hinyokika kiyo. Acta urologica Japonica
Schlagworte:	Clinical Trial English Abstract Journal Article Multicenter Study Randomized Controlled Trial Delayed-Action Preparations Gonadotropin-Releasing Hormone 33515-09-2 Leuprolide EFY6W0M8TG